Daily irradiation versus irradiation at two- to three-day intervals in stereotactic radiotherapy for patients with 1-5 brain metastases: study protocol for a multicenter open-label randomized phase II trial

[1] Chang JY(2015)Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials Lancet Oncol 16 630-637

[2] Senan S(2021)Surgery versus stereotactic body radiotherapy for clinical stage I non-small-cell lung cancer: propensity score-matching analysis including the ratio of ground glass nodules Clin Transl Oncol 23 638-647

[3] Paul MA(2020)Conventionally fractionated radiation therapy versus stereotactic body radiation therapy for locally advanced pancreatic cancer (CRiSP): An international systematic review and meta-analysis Cancer. 126 2120-2131

[4] Mehran RJ(2008)Helical tomotherapy for brain metastases: dosimetric evaluation of treatment plans and early clinical results Technol Cancer Res Treat 7 417-424

[5] Louie AV(2020)Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial J Clin Oncol 38 2830-2838

[6] Balter P(1953)The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy Br J Radiol 26 638-648

[7] Tomita N(1999)Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome Radiother Oncol 53 113-117

[8] Okuda K(1996)Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck Radiother Oncol 41 31-39

[9] Osaga S(1979)Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation Br J Radiol 52 650-656

[10] Miyakawa A(1986)Tumor oxygenation and reoxygenation during radiation therapy: their importance in predicting tumor response Int J Radiat Oncol Biol Phys 12 681-685

[1] Chang JY(2015)Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials Lancet Oncol 16 630-637

[2] Senan S(2021)Surgery versus stereotactic body radiotherapy for clinical stage I non-small-cell lung cancer: propensity score-matching analysis including the ratio of ground glass nodules Clin Transl Oncol 23 638-647

[3] Paul MA(2020)Conventionally fractionated radiation therapy versus stereotactic body radiation therapy for locally advanced pancreatic cancer (CRiSP): An international systematic review and meta-analysis Cancer. 126 2120-2131

[4] Mehran RJ(2008)Helical tomotherapy for brain metastases: dosimetric evaluation of treatment plans and early clinical results Technol Cancer Res Treat 7 417-424

[5] Louie AV(2020)Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial J Clin Oncol 38 2830-2838

[6] Balter P(1953)The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy Br J Radiol 26 638-648

[7] Tomita N(1999)Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome Radiother Oncol 53 113-117

[8] Okuda K(1996)Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck Radiother Oncol 41 31-39

[9] Osaga S(1979)Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation Br J Radiol 52 650-656

[10] Miyakawa A(1986)Tumor oxygenation and reoxygenation during radiation therapy: their importance in predicting tumor response Int J Radiat Oncol Biol Phys 12 681-685